Metabolic-associated Fatty Liver Disease

• CLINICAL_TRIALS trial_result · 2026-04-24
  Clinical Trial Update: Effects of Meal Macronutrients on Postprandial Lipids [Phase 2]

  Phase 2 clinical trial update by the National Institute of Diabetes and Digestive and Kidney Diseases evaluating how meal macronutrients inf…

• CLINICAL_TRIALS trial_result · 2026-03-25
  Clinical Trial Update: Evaluation of the Effects of Orange Consumption on Carbohydrate and Lipid Metabolism in Subjects With MAFLD (Metabolic Associated Fatty Liver Disease) [NA]

  The clinical trial evaluating the effects of orange consumption on carbohydrate and lipid metabolism in metabolic associated fatty liver dis…

• CLINICAL_TRIALS trial_result · 2025-09-16
  Clinical Trial Update: Metabolic Associated Fatty Liver Disease and Pancreatic Steatosis in Obese Versus Lean Chronic Hepatitis B Patients

  A clinical trial comparing metabolic associated fatty liver disease and pancreatic steatosis in obese versus lean patients with chronic hepa…

• CLINICAL_TRIALS trial_result · 2025-07-11
  Clinical Trial Update: Benefits of Trimetazidine in MASLD Patients [Phase 2]

  A Phase 2 trial evaluating trimetazidine in Metabolic Associated Fatty Liver Disease has completed.

• CLINICAL_TRIALS trial_result · 2023-10-31
  Clinical Trial Update: Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD) [Phase 2]

  Phase 2 clinical trial investigating the potential benefits of itopride for metabolic-associated fatty liver disease (MAFLD).

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2022-10-04
  Clinical Trial Update: Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D [Phase 4]

  Phase 4 trial investigating the effects of empagliflozin and dulaglutide on metabolic-associated fatty liver disease in patients with type 2…